Literature DB >> 28503437

Comparison of postoperative optical quality according to the degree of decentering of V4c implantable collamer lens.

Min Ji Park1, Hye Min Jeon1, Kyoung Heon Lee1, Sang Youp Han1.   

Abstract

AIM: To evaluate the clinical outcomes of V4c implantable collamer lens (Hole ICL) implantation with regard to the optical quality assessed according to different degrees of decentering.
METHODS: This included 49 eyes that received conventional ICL and 94 eyes that received Hole ICL. The eyes that received Hole ICL were divided into three groups according to the degree of decentering: group 1, central hole within 1 hole diameter (HD) from the pupil center; group 2, central hole within 1 HD to 2 HD; and group 3, central hole within 2 HD to 3 HD. Visual acuity (VA), intraocular pressure (IOP), and spherical equivalent (SE) values were assessed at 1wk, 1 and 3mo after surgery. The ocular modulation transfer function, Strehl ratio, objective scattering index, and higher order aberrations (HOAs) were measured for 4-mm pupils at 3mo after surgery.
RESULTS: There were no significant differences in VA, IOP, and SE among the conventional and Hole ICL groups. With regard to HOAs, values for coma and spherical aberrations showed no differences. The total HOA and trefoil values were significantly higher in group 2 than in group 1 (P=0.02, 0.03, respectively). There were no significant differences among groups with regard to other optical quality parameter at 3mo after surgery.
CONCLUSION: Our results suggest that Hole ICL implantation provides satisfactory visual quality that is equivalent to that provided by conventional ICL, regardless of the presence of central hole and degree of decentering.

Entities:  

Keywords:  implantable collamer lens; optical quality; phakic IOL; refractive surgery

Year:  2017        PMID: 28503437      PMCID: PMC5406642          DOI: 10.18240/ijo.2017.04.19

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

1.  Visual quality comparison of conventional and Hole-Visian implantable collamer lens at different degrees of decentering.

Authors:  Cari Pérez-Vives; Teresa Ferrer-Blasco; David Madrid-Costa; Santiago García-Lázaro; Robert Montés-Micó
Journal:  Br J Ophthalmol       Date:  2013-11-18       Impact factor: 4.638

2.  Early clinical outcomes of implantation of posterior chamber phakic intraocular lens with a central hole (Hole ICL) for moderate to high myopia.

Authors:  Kimiya Shimizu; Kazutaka Kamiya; Akihito Igarashi; Tetsu Shiratani
Journal:  Br J Ophthalmol       Date:  2011-07-06       Impact factor: 4.638

3.  Toric Implantable Collamer Lens for moderate to high myopic astigmatism.

Authors:  Donald R Sanders; David Schneider; Robert Martin; David Brown; David Dulaney; John Vukich; Stephen Slade; Steven Schallhorn
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

4.  Pigmentary dispersion syndrome induced by a posterior chamber phakic refractive lens.

Authors:  J D Brandt; M E Mockovak; A Chayet
Journal:  Am J Ophthalmol       Date:  2001-02       Impact factor: 5.258

5.  U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia.

Authors:  Donald R Sanders; John A Vukich; Kimberley Doney; Monica Gaston
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

6.  Clinical outcomes after implantation of a posterior chamber collagen copolymer phakic intraocular lens with a central hole for myopic correction.

Authors:  José F Alfonso; Carlos Lisa; Luis Fernández-Vega Cueto; Lurdes Belda-Salmerón; David Madrid-Costa; Robert Montés-Micó
Journal:  J Cataract Refract Surg       Date:  2013-06       Impact factor: 3.351

7.  Refractory intraocular pressure increase after phakic posterior chamber intraocular lens implantation.

Authors:  César A Sánchez-Galeana; David Zadok; Miguel Montes; Marco A Cortés; Arturo S Chayet
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

8.  Comparison of optical quality and intraocular scattering after posterior chamber phakic intraocular lens with and without a central hole (Hole ICL and Conventional ICL) implantation using the double-pass instrument.

Authors:  Kazutaka Kamiya; Kimiya Shimizu; Aya Saito; Akihito Igarashi; Hidenaga Kobashi
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

9.  Posterior chamber phakic intraocular lens for hyperopia of +4 to +11 diopters.

Authors:  J M Davidorf; R Zaldivar; S Oscherow
Journal:  J Refract Surg       Date:  1998 May-Jun       Impact factor: 3.573

10.  Long-Term Comparison of Posterior Chamber Phakic Intraocular Lens With and Without a Central Hole (Hole ICL and Conventional ICL) Implantation for Moderate to High Myopia and Myopic Astigmatism: Consort-Compliant Article.

Authors:  Kimiya Shimizu; Kazutaka Kamiya; Akihito Igarashi; Hidenaga Kobashi
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more
  4 in total

1.  Effects of tilt and decentration of Visian Implantable Collamer Lens (ICL V4c) on visual quality: an observational study.

Authors:  Lingling Niu; Zhe Zhang; Huamao Miao; Jing Zhao; Meiyan Li; Ji C He; Peijun Yao; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2022-07-05       Impact factor: 2.086

2.  Short-time evaluation on intraocular scattering after implantable collamer lens implantation for correcting high myopia.

Authors:  Zhe Yu; Jun Li; Hui Song
Journal:  BMC Ophthalmol       Date:  2020-06-17       Impact factor: 2.209

Review 3.  In vivo optical quality of posterior-chamber phakic implantable collamer lenses with a central port.

Authors:  Robert Montés-Micó; Francisco Pastor-Pascual; Enrique Artiaga-Elordi; Ramón Ruiz-Mesa; Pedro Tañá-Rivero
Journal:  Eye Vis (Lond)       Date:  2021-08-16

4.  Safety of implantable Collamer lens implantation without ophthalmic viscosurgical device: A retrospective cohort study.

Authors:  Manqiang Peng; Qiongyan Tang; Libei Zhao; Muhanmad Ahmad Khan; Ding Lin
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.